882291

Alan E. Nolasco, M. D. — FEI 3010510442

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
June 10, 2014
Fiscal Year
2014
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Houston, TX (United States)

Additional Details

Clinical Investigator (CI)

Citations

IDCFRDescription
756221 CFR 312.60Informed consent